131 related articles for article (PubMed ID: 12479880)
1. Effects of insulin on platelet and leukocyte activity in whole blood.
Hu H; Hjemdahl P; Li N
Thromb Res; 2002 Sep; 107(5):209-15. PubMed ID: 12479880
[TBL] [Abstract][Full Text] [Related]
2. Contrast medium attenuates platelet activation and platelet-leukocyte cross-talk.
Ji Q; Ghaly M; Hjemdahl P; Tornvall P; Li N
Thromb Haemost; 2005 May; 93(5):922-6. PubMed ID: 15886810
[TBL] [Abstract][Full Text] [Related]
3. Insulin, but not proinsulin C-peptide, enhances platelet fibrinogen binding in vitro in Type 1 diabetes mellitus patients and healthy subjects.
Hu H; Li N; Ekberg K; Johansson BL; Hjemdahl P
Thromb Res; 2002 Apr; 106(2):91-5. PubMed ID: 12182905
[TBL] [Abstract][Full Text] [Related]
4. Evidence for prothrombotic effects of exercise and limited protection by aspirin.
Li N; Wallén NH; Hjemdahl P
Circulation; 1999 Sep; 100(13):1374-9. PubMed ID: 10500036
[TBL] [Abstract][Full Text] [Related]
5. Enhanced leukocyte-platelet cross-talk in Type 1 diabetes mellitus: relationship to microangiopathy.
Hu H; Li N; Yngen M; Ostenson CG; Wallén NH; Hjemdahl P
J Thromb Haemost; 2004 Jan; 2(1):58-64. PubMed ID: 14717967
[TBL] [Abstract][Full Text] [Related]
6. Parnaparin, a low-molecular-weight heparin, prevents P-selectin-dependent formation of platelet-leukocyte aggregates in human whole blood.
Maugeri N; Di Fabio G; Barbanti M; de Gaetano G; Donati MB; Cerletti C
Thromb Haemost; 2007 Jun; 97(6):965-73. PubMed ID: 17549299
[TBL] [Abstract][Full Text] [Related]
7. Platelet-leukocyte cross talk in whole blood.
Li N; Hu H; Lindqvist M; Wikström-Jonsson E; Goodall AH; Hjemdahl P
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2702-8. PubMed ID: 11116075
[TBL] [Abstract][Full Text] [Related]
8. Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry.
Li N; Hu H; Hjemdahl P
Thromb Res; 2003; 111(3):165-70. PubMed ID: 14678815
[TBL] [Abstract][Full Text] [Related]
9. The effects of sevoflurane and desflurane in vitro on platelet-leukocyte adhesion in whole blood.
Horn NA; de Rossi L; Robitzsch T; Hecker KE; Hutschenreuter G; Rossaint R
Anaesthesia; 2003 Apr; 58(4):312-9. PubMed ID: 12648111
[TBL] [Abstract][Full Text] [Related]
10. Chimeric 7E3 Fab (ReoPro) decreases detectable CD11b on neutrophils from patients undergoing coronary angioplasty.
Mickelson JK; Ali MN; Kleiman NS; Lakkis NM; Chow TW; Hughes BJ; Smith CW
J Am Coll Cardiol; 1999 Jan; 33(1):97-106. PubMed ID: 9935015
[TBL] [Abstract][Full Text] [Related]
11. Determinants of platelet conjugate formation with polymorphonuclear leukocytes or monocytes in whole blood.
Izzi B; Pampuch A; Costanzo S; Vohnout B; Iacoviello L; Cerletti C; de Gaetano G
Thromb Haemost; 2007 Dec; 98(6):1276-84. PubMed ID: 18064325
[TBL] [Abstract][Full Text] [Related]
12. High glucose levels enhance platelet activation: involvement of multiple mechanisms.
Sudic D; Razmara M; Forslund M; Ji Q; Hjemdahl P; Li N
Br J Haematol; 2006 May; 133(3):315-22. PubMed ID: 16643434
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase III inhibition affects platelet-monocyte aggregate formation depending on the axis of stimulation.
Horn NA; Anastase DM; Hecker KE; Baumert JH; Scheffer GJ; Rossaint R
J Cardiothorac Vasc Anesth; 2006 Apr; 20(2):162-6. PubMed ID: 16616654
[TBL] [Abstract][Full Text] [Related]
14. Role of platelet-activating factor in aggregation of leukocytes and platelets in cerebral ischemia.
Uchiyama S; Yamazaki M; Maruyama S
Lipids; 1991 Dec; 26(12):1247-9. PubMed ID: 1819711
[TBL] [Abstract][Full Text] [Related]
15. Exercise-induced platelet and leucocyte activation is not enhanced in well-controlled Type 1 diabetes, despite increased activity at rest.
Hu H; Johansson BL; Hjemdahl P; Li N
Diabetologia; 2004 May; 47(5):853-9. PubMed ID: 15095037
[TBL] [Abstract][Full Text] [Related]
16. Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor.
Hammerschmidt DE; Kotasek D; McCarthy T; Huh PW; Freyburger G; Vercellotti GM
J Lab Clin Med; 1988 Aug; 112(2):254-63. PubMed ID: 2840477
[TBL] [Abstract][Full Text] [Related]
17. Epinephrine enhances platelet-neutrophil adhesion in whole blood in vitro.
Horn NA; Anastase DM; Hecker KE; Baumert JH; Robitzsch T; Rossaint R
Anesth Analg; 2005 Feb; 100(2):520-526. PubMed ID: 15673886
[TBL] [Abstract][Full Text] [Related]
18. Effect of halothane and isoflurane on binding of ADP- and TRAP-6- activated platelets to leukocytes in Whole blood.
de Rossi LW; Horn NA; Hecker KE; Robitzsch T; Hutschenreuter G; Rossaint R
Anesthesiology; 2002 Jan; 96(1):117-24. PubMed ID: 11753011
[TBL] [Abstract][Full Text] [Related]
19. The complement factor properdin induces formation of platelet-leukocyte aggregates via leukocyte activation.
Ruef J; Kuehnl P; Meinertz T; Merten M
Platelets; 2008 Aug; 19(5):359-64. PubMed ID: 18791942
[TBL] [Abstract][Full Text] [Related]
20. Insulin enhances platelet activation in vitro.
Yngen M; Li N; Hjemdahl P; Wallén NH
Thromb Res; 2001 Oct; 104(2):85-91. PubMed ID: 11672752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
